Associate Professor; Center for Head and Neck Oncology
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA, United States
Dr. Hanna completed his fellowship training in medical oncology at Dana-Farber Cancer Institute in 2016. Prior to this, he earned his medical degree from Georgetown University School of Medicine in 2010, where he graduated summa cum laude, a member of Alpha Omega Alpha Honor Society and the Kober Medalist for academic excellence. He joined the faculty of the Center for Head and Neck Oncology in 2017. Dr. Hanna is the Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI and an Associate Professor of Medicine at Harvard Medical School. His clinical and translational research efforts focus on precision medicine approaches to treat head and neck cancers.
Sunday, October 18, 2026
4:00 PM - 5:00 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.